Kardex Holding AG
LSE:0QOL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kardex Holding AG
LSE:0QOL
|
CH |
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
O
|
Oversea-Chinese Banking Corporation Ltd
SWB:OCBA
|
SG |
|
HKScan Oyj
LSE:0ISM
|
FI |
|
P
|
PWO AG
XMUN:PWO
|
DE |
|
GSH Corporation Ltd
SGX:BDX
|
SG |
Wall St Price Targets
0QOL Price Targets Summary
Kardex Holding AG
According to Wall Street analysts, the average 1-year price target for 0QOL is 358.98 CHF with a low forecast of 334.76 CHF and a high forecast of 395.48 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QOL's stock price target?
Price Target
358.98
CHF
According to Wall Street analysts, the average 1-year price target for 0QOL is 358.98 CHF with a low forecast of 334.76 CHF and a high forecast of 395.48 CHF.
What is the Revenue forecast for Kardex Holding AG?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Kardex Holding AG?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Kardex Holding AG?
Projected CAGR
44%
Over the last 14 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 3 years is 44%.
